CO5611144A2 - Uso de 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas para producir medicamentos con un efecto inhibidor sobre la lipasa pancreatica - Google Patents

Uso de 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas para producir medicamentos con un efecto inhibidor sobre la lipasa pancreatica

Info

Publication number
CO5611144A2
CO5611144A2 CO04083781A CO04083781A CO5611144A2 CO 5611144 A2 CO5611144 A2 CO 5611144A2 CO 04083781 A CO04083781 A CO 04083781A CO 04083781 A CO04083781 A CO 04083781A CO 5611144 A2 CO5611144 A2 CO 5611144A2
Authority
CO
Colombia
Prior art keywords
alkyl
groups
substituted
alkyloxy
aryl
Prior art date
Application number
CO04083781A
Other languages
English (en)
Spanish (es)
Inventor
Karl Schoenafinge
Stefan Petry
Guenter Mueller
Armin Bauer
Hubert Otto Heuer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of CO5611144A2 publication Critical patent/CO5611144A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO04083781A 2002-02-28 2004-08-26 Uso de 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas para producir medicamentos con un efecto inhibidor sobre la lipasa pancreatica CO5611144A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208986A DE10208986A1 (de) 2002-02-28 2002-02-28 Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase

Publications (1)

Publication Number Publication Date
CO5611144A2 true CO5611144A2 (es) 2006-02-28

Family

ID=27740557

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04083781A CO5611144A2 (es) 2002-02-28 2004-08-26 Uso de 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas para producir medicamentos con un efecto inhibidor sobre la lipasa pancreatica

Country Status (20)

Country Link
EP (1) EP1482929A1 (fr)
JP (1) JP2005519079A (fr)
KR (1) KR20040101250A (fr)
CN (1) CN1638766A (fr)
AR (1) AR038702A1 (fr)
AU (1) AU2003210292A1 (fr)
BR (1) BR0308045A (fr)
CA (1) CA2477005A1 (fr)
CO (1) CO5611144A2 (fr)
DE (1) DE10208986A1 (fr)
HR (1) HRP20040783A2 (fr)
HU (1) HUP0500093A2 (fr)
IL (1) IL163719A0 (fr)
MA (1) MA27173A1 (fr)
MX (1) MXPA04007480A (fr)
NO (1) NO20044091L (fr)
PL (1) PL371310A1 (fr)
RU (1) RU2004128932A (fr)
TW (1) TW200400026A (fr)
WO (1) WO2003072098A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI359812B (en) 2004-06-17 2012-03-11 Cytokinetics Inc Compounds, compositions and methods
MX2007004889A (es) 2004-10-25 2007-09-11 Solvay Pharm Gmbh Composiciones farmaceuticas que comprenden antagonistas del receptor cannabinoide cb1 y activadores de canales de potasio para el tratamiento de la diabetes mellitus tipo i, la obesidad y trastornos relacionados.
TW200808321A (en) 2005-12-15 2008-02-16 Cytokinetics Inc Certain chemical entities, compositions and methods
US7825120B2 (en) 2005-12-15 2010-11-02 Cytokinetics, Inc. Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
JP5178526B2 (ja) 2005-12-19 2013-04-10 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
KR101613610B1 (ko) * 2007-12-25 2016-04-19 깃세이 야쿠힌 고교 가부시키가이샤 신규한 카테콜 유도체, 그것을 함유하는 의약 조성물 및 그것들의 용도
WO2010074587A2 (fr) 2008-12-23 2010-07-01 Bial - Portela & Ca., S.A. 3-n-aryl-1,3,4-oxadiazolones 5-o-substituées destinées à une utilisation médicale
CN103086859B (zh) * 2011-11-08 2015-11-11 清华大学 2,4-二羟基-5,6-取代-1-卤代苯衍生物、其合成方法及其应用
EP3676243A4 (fr) * 2017-09-01 2021-05-26 Curtin University Dérivés synthétiques de oléoyl-lysophosphatidylinositol (oléolyl-lpi) et utilisations associées
CN109879839B (zh) * 2019-03-12 2023-04-25 沈阳大学 6-哌嗪甲基-7-羟基苯并呋喃类化合物及其医药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
HUP0302772A3 (en) * 2000-03-07 2007-03-28 Sanofi Aventis Deutschland Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase

Also Published As

Publication number Publication date
RU2004128932A (ru) 2005-04-10
HRP20040783A2 (en) 2005-04-30
HUP0500093A2 (hu) 2005-04-28
DE10208986A1 (de) 2003-09-11
TW200400026A (en) 2004-01-01
PL371310A1 (en) 2005-06-13
KR20040101250A (ko) 2004-12-02
AU2003210292A1 (en) 2003-09-09
CN1638766A (zh) 2005-07-13
JP2005519079A (ja) 2005-06-30
NO20044091L (no) 2004-09-27
IL163719A0 (en) 2005-12-18
MA27173A1 (fr) 2005-01-03
WO2003072098A1 (fr) 2003-09-04
BR0308045A (pt) 2004-12-21
MXPA04007480A (es) 2004-11-10
CA2477005A1 (fr) 2003-09-04
AR038702A1 (es) 2005-01-26
EP1482929A1 (fr) 2004-12-08

Similar Documents

Publication Publication Date Title
CO5611144A2 (es) Uso de 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas para producir medicamentos con un efecto inhibidor sobre la lipasa pancreatica
CO4650042A1 (es) Derivados de 6-fenilpiridil-2-amina
CO4950619A1 (es) Derivados de acido arilsulfonil hidroxamico
CO5690597A2 (es) Derivados de hexahidropirazino[1,2-a]pirimidina-4,7-diona sustituidos, metodo para producirlos y sus uso cxomo medicamentos
CO5021127A1 (es) Nuevas dihidropirimidas
AR015765A1 (es) Dihidropirimidinas 2 heterociclicamente sustituidas, proceso para su preparacion, medicamentos que los contienen, proceso para la preparacion de los mismosuso de dichos dihidropirimidinas para la preparacion de un medicamento.
CO5261626A1 (es) Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialemente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologica
AR025884A1 (es) Compuestos de amina ciclica, su produccion y su uso
CR8595A (es) Inhibidor del dipeptidil-peptidasa
BRPI0508464B8 (pt) sulfonilpirróis, composição farmacêutica compreendendo os mesmos e uso dos mesmos
CO6160235A2 (es) Isoxazolinas insecticidas
ES2436020T3 (es) Derivados de sulfonamida sustituidos
DK0494819T3 (da) Hidtil ukendte phenylimidazolidiner, deres fremstilling, anvendelse som lægemidler samt farmaceutiske præparater med indhold heraf
ECSP099062A (es) Derivados novedosos de aminopiridina que tienen acción inhibidora selectiva sobre aurora a
ES2150671T3 (es) Compuesto de bencimidazol y su utilizacion como moduladores del complejo de receptores gaba-a.
DK157295C (da) Tetrahydrobenzindoler og deres anvendelse som laegemidler
NO20072005L (no) Nye heterocykliske amider
CO4810374A1 (es) Nueva utilizacion de compuestos para actividad anti- pruritica
AR042362A1 (es) Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen
CO6160310A2 (es) Nuevos derivados imidazolonas su preparacion como medicamentos composiciones farmaceuticas utilizacion como inhibidores de proteinas quinasas principalmente cdc7
AR016644A1 (es) Compuestos de 2-aminopiridinas con sustituyentes alcoxi ramificados, composicion farmaceutica y uso para la manufactura de medicamentos
AR007088A1 (es) 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas
HUP0202988A2 (hu) Szubsztituált 3-fenil-5-alkoxi-1,3,4-oxadiazol-2-on-származékok és lipán inhibitorként történő alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ES2165193T3 (es) Metodo para aumentar la actividad de una enzima.
ES2185316T3 (es) Butirolactonas alfa, beta-condensadas sustituidas.

Legal Events

Date Code Title Description
FA Application withdrawn